Myomo Inc Stock Fundamentals
| MYO Stock | USD 3.64 0.04 1.09% |
Myomo Inc fundamentals help investors to digest information that contributes to Myomo's financial success or failures. It also enables traders to predict the movement of Myomo Stock. The fundamental analysis module provides a way to measure Myomo's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Myomo stock.
At this time, Myomo's Total Other Income Expense Net is very stable compared to the past year. As of the 19th of May 2024, Interest Income is likely to grow to about 620.3 K, while Selling General Administrative is likely to drop about 10.3 M. Myomo | Select Account or Indicator |
Myomo Inc Company Return On Asset Analysis
Myomo's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Myomo Return On Asset | -0.42 |
Most of Myomo's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Myomo Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Myomo Total Assets
Total Assets |
|
Based on the latest financial disclosure, Myomo Inc has a Return On Asset of -0.4158. This is 95.25% lower than that of the Health Care Equipment & Supplies sector and 97.7% lower than that of the Health Care industry. The return on asset for all United States stocks is 197.0% higher than that of the company.
Myomo Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Myomo's current stock value. Our valuation model uses many indicators to compare Myomo value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Myomo competition to find correlations between indicators driving Myomo's intrinsic value. More Info.Myomo Inc is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . At this time, Myomo's Return On Equity is very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Myomo by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Myomo's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Myomo's earnings, one of the primary drivers of an investment's value.Myomo Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Myomo's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Myomo could also be used in its relative valuation, which is a method of valuing Myomo by comparing valuation metrics of similar companies.Myomo is currently under evaluation in return on asset category among related companies.
Myomo Current Valuation Drivers
We derive many important indicators used in calculating different scores of Myomo from analyzing Myomo's financial statements. These drivers represent accounts that assess Myomo's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Myomo's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 5.0M | 22.4M | 39.9M | 3.6M | 147.8M | 155.2M | |
| Enterprise Value | 3.2M | 10.3M | 25.1M | (1.2M) | 141.5M | 148.6M |
Myomo ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Myomo's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Myomo's managers, analysts, and investors.Environmental | Governance | Social |
Myomo Fundamentals
| Return On Equity | -1.06 | ||||
| Return On Asset | -0.42 | ||||
| Profit Margin | (0.42) % | ||||
| Operating Margin | (0.51) % | ||||
| Current Valuation | 103.69 M | ||||
| Shares Outstanding | 28.81 M | ||||
| Shares Owned By Insiders | 12.68 % | ||||
| Shares Owned By Institutions | 46.80 % | ||||
| Number Of Shares Shorted | 678.19 K | ||||
| Price To Earning | (0.30) X | ||||
| Price To Book | 9.41 X | ||||
| Price To Sales | 4.40 X | ||||
| Revenue | 19.24 M | ||||
| Gross Profit | 10.25 M | ||||
| EBITDA | (7.71 M) | ||||
| Net Income | (8.15 M) | ||||
| Cash And Equivalents | 5.35 M | ||||
| Cash Per Share | 1.46 X | ||||
| Total Debt | 601.3 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 3.42 X | ||||
| Book Value Per Share | 0.33 X | ||||
| Cash Flow From Operations | (6.17 M) | ||||
| Short Ratio | 3.23 X | ||||
| Earnings Per Share | (0.28) X | ||||
| Target Price | 5.6 | ||||
| Number Of Employees | 101 | ||||
| Beta | 1.5 | ||||
| Market Capitalization | 104.89 M | ||||
| Total Asset | 14.58 M | ||||
| Retained Earnings | (96.93 M) | ||||
| Working Capital | 8.17 M | ||||
| Current Asset | 5.11 M | ||||
| Current Liabilities | 2.31 M | ||||
| Net Asset | 14.58 M |
About Myomo Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Myomo Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Myomo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Myomo Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 8.5 K | 8.1 K | |
| Total Revenue | 19.2 M | 20.2 M | |
| Cost Of Revenue | 6.1 M | 6.4 M | |
| Stock Based Compensation To Revenue | 0.06 | 0.06 | |
| Sales General And Administrative To Revenue | 0.81 | 0.77 | |
| Research And Ddevelopement To Revenue | 0.14 | 0.13 | |
| Capex To Revenue | (0.01) | (0.01) | |
| Revenue Per Share | 0.65 | 0.62 | |
| Ebit Per Revenue | (0.43) | (0.45) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Myomo Piotroski F Score and Myomo Altman Z Score analysis. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Myomo Stock analysis
When running Myomo's price analysis, check to measure Myomo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myomo is operating at the current time. Most of Myomo's value examination focuses on studying past and present price action to predict the probability of Myomo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Myomo's price. Additionally, you may evaluate how the addition of Myomo to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Myomo's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share 0.652 | Quarterly Revenue Growth 0.177 | Return On Assets (0.42) | Return On Equity (1.06) |
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.